Cargando…

Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury

CONTEXT: Protocatechuic acid (PCA) has a protective effect on alcoholic liver injury, but the role of PCA in type 2 diabetes-induced liver injury is not well known. OBJECTIVES: This study explores the therapeutic effect and potential mechanism of PCA on type 2 diabetes-induced liver injury. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Kaixia, Lu, Guang, Feng, Qianjin, Chen, Shuangchao, Wang, Yonghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155631/
https://www.ncbi.nlm.nih.gov/pubmed/37129023
http://dx.doi.org/10.1080/13880209.2023.2181359
_version_ 1785036371260342272
author Xu, Kaixia
Lu, Guang
Feng, Qianjin
Chen, Shuangchao
Wang, Yonghui
author_facet Xu, Kaixia
Lu, Guang
Feng, Qianjin
Chen, Shuangchao
Wang, Yonghui
author_sort Xu, Kaixia
collection PubMed
description CONTEXT: Protocatechuic acid (PCA) has a protective effect on alcoholic liver injury, but the role of PCA in type 2 diabetes-induced liver injury is not well known. OBJECTIVES: This study explores the therapeutic effect and potential mechanism of PCA on type 2 diabetes-induced liver injury. MATERIALS AND METHODS: An insulin resistance/type 2 diabetic (IR/D) model was established by high-fat diet for 4 weeks + streptozotocin (35 mg/kg; i.p) in male Wistar rats pretreated with or without PCA (15 or 30 mg/kg for 6 d). RESULTS: PCA at 15 and 30 mg/kg significantly upregulated the levels of body weight (BW; 230.2, 257.8 g), high density lipids (22.68, 34.78 mg/dL), glutathione (10.24, 16.21 nmol/mg), superoxide dismutase (21.62, 29.34 U/mg), glucagon-like peptide-1, glucose transporter-4, Wnt1, and β-catenin, while downregulating those of liver weight (LW; 9.4, 6.7 g), BW/LW (4.1, 2.6%), serum glucose (165, 120 mg/dL), serum insulin (13.46, 8.67 μIU/mL), homeostatic model assessment of insulin resistance (5.48, 2.57), total cholesterol (68.52, 54.31 mg/dL), triglycerides (72.15, 59.64 mg/dL), low density lipids (42.18, 30.71), aspartate aminotransferase (54.34 and 38.68 U/L), alanine aminotransferase (42.87, 29.98 U/L), alkaline phosphatase (210.16, 126.47 U/L), malondialdehyde (16.52, 10.35), pro-inflammatory markers (tumor necrosis factor α (TNF-α (149.67, 120.33 pg/mg)) , IL-6 (89.79, 73.69 pg/mg) and IL-1β (49.67, 38.73 pg/mg)), nuclear factor kappa B (NF-κB), and interleukin-1β, and ameliorated the abnormal pathological changes in IR/D rats. DISCUSSION AND CONCLUSION: PCA mitigates the IR, lipid accumulation, oxidative stress, and inflammation in liver tissues of IR/D rats by modulating the NF-κB and Wnt1/β-catenin pathways.
format Online
Article
Text
id pubmed-10155631
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-101556312023-05-04 Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury Xu, Kaixia Lu, Guang Feng, Qianjin Chen, Shuangchao Wang, Yonghui Pharm Biol Research Article CONTEXT: Protocatechuic acid (PCA) has a protective effect on alcoholic liver injury, but the role of PCA in type 2 diabetes-induced liver injury is not well known. OBJECTIVES: This study explores the therapeutic effect and potential mechanism of PCA on type 2 diabetes-induced liver injury. MATERIALS AND METHODS: An insulin resistance/type 2 diabetic (IR/D) model was established by high-fat diet for 4 weeks + streptozotocin (35 mg/kg; i.p) in male Wistar rats pretreated with or without PCA (15 or 30 mg/kg for 6 d). RESULTS: PCA at 15 and 30 mg/kg significantly upregulated the levels of body weight (BW; 230.2, 257.8 g), high density lipids (22.68, 34.78 mg/dL), glutathione (10.24, 16.21 nmol/mg), superoxide dismutase (21.62, 29.34 U/mg), glucagon-like peptide-1, glucose transporter-4, Wnt1, and β-catenin, while downregulating those of liver weight (LW; 9.4, 6.7 g), BW/LW (4.1, 2.6%), serum glucose (165, 120 mg/dL), serum insulin (13.46, 8.67 μIU/mL), homeostatic model assessment of insulin resistance (5.48, 2.57), total cholesterol (68.52, 54.31 mg/dL), triglycerides (72.15, 59.64 mg/dL), low density lipids (42.18, 30.71), aspartate aminotransferase (54.34 and 38.68 U/L), alanine aminotransferase (42.87, 29.98 U/L), alkaline phosphatase (210.16, 126.47 U/L), malondialdehyde (16.52, 10.35), pro-inflammatory markers (tumor necrosis factor α (TNF-α (149.67, 120.33 pg/mg)) , IL-6 (89.79, 73.69 pg/mg) and IL-1β (49.67, 38.73 pg/mg)), nuclear factor kappa B (NF-κB), and interleukin-1β, and ameliorated the abnormal pathological changes in IR/D rats. DISCUSSION AND CONCLUSION: PCA mitigates the IR, lipid accumulation, oxidative stress, and inflammation in liver tissues of IR/D rats by modulating the NF-κB and Wnt1/β-catenin pathways. Taylor & Francis 2023-05-02 /pmc/articles/PMC10155631/ /pubmed/37129023 http://dx.doi.org/10.1080/13880209.2023.2181359 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Research Article
Xu, Kaixia
Lu, Guang
Feng, Qianjin
Chen, Shuangchao
Wang, Yonghui
Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
title Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
title_full Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
title_fullStr Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
title_full_unstemmed Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
title_short Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
title_sort hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155631/
https://www.ncbi.nlm.nih.gov/pubmed/37129023
http://dx.doi.org/10.1080/13880209.2023.2181359
work_keys_str_mv AT xukaixia hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury
AT luguang hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury
AT fengqianjin hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury
AT chenshuangchao hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury
AT wangyonghui hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury